Grandeur Peak Global Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,418
Closed -$222K 114
2022
Q4
$222K Buy
19,418
+621
+3% +$9.2K 0.01% 107
2022
Q3
$320K Hold
18,797
0.02% 108
2022
Q2
$404K Buy
18,797
+16,450
+701% +$456K 0.03% 106
2022
Q1
$87K Buy
+2,347
New +$91.5K ﹤0.01% 112

Other funds holding CDNA

Grandeur Peak Global Advisors's CDNA Position: Q1 2023 in Review

Grandeur Peak Global Advisors sold out of CareDx (CDNA) in Q1 2023, closing a stake of 19,418 shares — an estimated $222K sold.

Grandeur Peak Global Advisors first reported a position in CDNA in Q1 2022 and held it in 4 quarters. The position peaked at $404K in Q2 2022. 156 funds tracked by Wall St. Rank hold CDNA as of Q1 2023.

  • Grandeur Peak Global Advisors reported no remaining CareDx position as of Q1 2023 after selling out during the quarter.
  • Grandeur Peak Global Advisors sold 19,418 CareDx shares in Q1 2023, an estimated $222K.
  • Grandeur Peak Global Advisors first reported a position in CareDx in Q1 2022 and held it in 4 quarters.
  • Grandeur Peak Global Advisors's CareDx position peaked at $404K in Q2 2022.
  • 156 funds tracked by Wall St. Rank held CareDx as of Q1 2023.

Based on Grandeur Peak Global Advisors's 13F filing for Q1 2023, filed 12 May 2023.